- published: 25 Oct 2013
- views: 10110
Neonatal withdrawal or neonatal abstinence syndrome (NAS) is a withdrawal syndrome of infants, caused by the cessation of the administration of licit or illicit drugs. Tolerance, dependence, and withdrawal may occur as a result of repeated administration of drugs or even after short-term high dose use—for example during mechanical ventilation in intensive care units. There are two types of NAS: prenatal and postnatal. Prenatal NAS is caused by discontinuation of drugs taken by the pregnant mother, while postnatal NAS is caused by discontinuation of drugs directly to the infant.
The drugs involved may be for example opioids, selective serotonin reuptake inhibitors (SSRIs), ethanol and benzodiazepines. Neonatal abstinence syndrome does not happen in prenatal cocaine exposure (with babies exposed to cocaine in utero) in the sense that such symptoms are difficult to separate in the context of other factors such as prematurity or prenatal exposure to other drugs.
When pharmacological treatment of opiate withdrawal in neonates is deemed necessary, opiates are the treatment of choice; they are slowly tapered down to wean the neonate off opiates.Phenobarbital is sometimes used as an alternative but is less effective in suppressing seizures; however, phenobarbital is superior to diazepam for neonatal opiate withdrawal symptoms. In the case of sedative-hypnotic neonatal withdrawal, phenobarbital is the treatment of choice.Clonidine is an emerging add-on therapy.Buprenorphine is under development as an alternative to morphine or methadone as initial therapy.
Neonatal Abstinence Syndrome
Neonatal Abstinence Syndrome
Neonatal Abstinence Syndrome
Newborn opiate withdrawal symptom- tremors
When babies are born withdrawing from opioids
Fighting Neonatal Abstinence Syndrome (NAS) - East Tennessee Children's Hospital NICU
Stories Not Secrets: Neonatal Abstinence Syndrome
Neonatal Abstinence Syndrome (NAS)
PSA Neonatal Abstinence Syndrome
Neonatal Abstinence Syndrome And The Consequences of Opiate Withdrawal In Newborns
Presented by DuBois Regional Medical Center/Clearfield-Jefferson Drug and Alcohol Commission
A short movie on neonatal abstinence syndrome by Bradie and Elise
In this presentation, Jacinda Hays, D.O., discusses the clinical presentation of Neonatal Abstinence Syndrome (NAS) and how to uses the Finegan scoring system to determine severity. She also reviews how this is becoming a public health crisis and how Carilion Children’s is responding. This is a recording from a live Pediatric Grand Rounds webcast in January 2016.
Neonatal abstinence syndrome, NAS 2 1/2 month old baby releases from nicu and home for one week now. Remnants of withdrawal. Symptom- tremors. Off all medication (morphine, colondine, phenobarbital) for two weeks now.
The number of American babies born going through withdrawal from prescription painkillers and heroin used by their mothers during pregnancy, a condition called Neonatal Abstinence Syndrome, increased fivefold between 2000 and 2012. NewsHour's Alison Stewart explores the consequences of the painful condition on mothers and infants.
Neonatal abstinence syndrome is a growing problem in Tennessee, and the NICU at East Tennessee Children's Hospital is one of the best facilities in the country to treat babies with NAS. Find out more at: https://www.etch.com/about/specialties/neonatal-intensive-care/
This video aims to help educate the public of the risks of opioid dependency during pregnancy. The video, released April 22, 2016, at an event in the Alpena County Circuit Courtroom, is a collaborative project of several health, human services, legal and community organizations in northern Michigan.
Evelyn Keppinger, Clinical Nurse Navigator, discusses Neonatal Abstinence Syndrome (NAS) and the management of infants with this syndrome. She also discusses the importance of parental education and transition planning for home care of these infants.
Kitana McSwain-Ford
Neonatal Abstinence Syndrome is when an infant goes through opiate withdrawal. When a pregnant woman is addicted to opiates and uses throughout her pregnancy, the baby will go through withdrawal immediately following the birth which can be extremely uncomfortable and even possibly deadly. You can read more here: http://calmsupport.com/blogs/news/15616252-neonatal-abstinence-syndrome-is-opiate-withdrawal-in-newborns-and-infants Questions or comments, please leave them below. Looking for an all natural home remedy for opiate withdrawal, visit http://CalmSupport.com Follow Us! Ryan’s Facebook: https://www.facebook.com/ryandonnellyfreefromhell Twitter: https://twitter.com/calmsupport CalmSupport Facebook: https://www.facebook.com/CalmSupport Youtube: https://www.youtube.com/user/calmsupp...
Learn about Neonatal Abstinence Syndrome (NAS), it's severe effect on mothers and newborn babies, and what VTM is doing to help.
Please sit back and enjoy this educational talk about neonatal abstinence syndrome. Presented by Dr. Salzmann, pediatrician at CGH Medical Center, as part of the Growing Healthier Series brought to you by the CGH Health Foundation.
Neonatal Abstinence Syndrome (NAS) is a growing problem in the United States. NAS occurs when newborn babies experience withdrawal after being exposed to drugs in the womb. Fortunately, NAS is preventable if an expectant mother receives proper care and treatment. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://www.cdc.gov/video/phgr/2016/GR_08-16-2016_LowRes.mp4
description
This documentary was created to prove there is a need for awareness of, and a solution to Neonatal Abstinence Syndrome. Directed by: Krista Adkins Credits: Kathy Bandy, Dawn Adkins, Jaide Bandy Sources: "Neonatal Abstinence Syndrome." Change in US NAS Incidence. Web. 06 May 2016. "Neonatal Abstinence Syndrome." Florida Department of Health. Web. 06 May 2016. "The Impact of Neonatal Abstinence Syndrome on One West Virginia Comm..." The Impact of Neonatal Abstinence Syndrome on One West Virginia Comm... Web. 06 May 2016. "Substance Abuse During Pregnancy: Will My Drug Addiction Hurt My Baby?" Decoded Pregnancy. Web. 06 May 2016
This Webcast presented a discussion of Neonatal Abstinence Syndrome (NAS) and quality improvement projects undertaken by perinatal and neonatal quality improvement collaboratives to address NAS, including project challenges and successes. It concludes with participant questions. The videos referenced in the presentation are part of a larger tool available from the Vermont Oxford Network. Comments on this video are allowed in accordance with our comment policy: http://www.cdc.gov/SocialMedia/Tools/CommentPolicy.html This video can also be viewed at http://www.cdc.gov/reproductivehealth/MaternalInfantHealth/PQC_Webinars.html
This session will center on Neonatal Abstinence Syndrome (NAS). We will discuss the epidemiology of NAS, the clinical presentation of and management of infants affected by withdrawal. We will also introduce innovative alternatives to hospital care for these babies that allows for a smooth transition into society. Objectives: •Discuss the epidemiology of NAS both nationally and regionally •Discuss the management of infants with NAS •Discuss our systems of care surrounding NAS Dr. Sean Loudin is a member of the Division of Neonatal-Perinatal Medicine at Marshall University and an Assistant Professor of Pediatrics at the Joan C. Edwards School of Medicine. He received his medical degree and completed his Pediatric residency at Marshall University. Dr. Loudin continued his training with a t...
Remarks by: Cecelia Spitznas, Senior Science Policy Advisor, White House Office of National Drug Control Policy, Executive Office of the President Detailed information available on our website: http://www.nihcm.org/webinar-neonatal-abstinence-syndrome-strategies-for-states-and-health-plans
Webinar hosted on July 16, 2014 by the National Institute for Health Care Management Foundation. Detailed information available on our website: http://www.nihcm.org/webinar-neonatal-abstinence-syndrome-strategies-for-states-and-health-plans